| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Nicholson, C. David serves as a Director at ATNM. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $12K at current prices.
The biggest single holding is ATNM (~$12K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 5,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2016 | ATNM Actinium Pharmaceuticals, Inc. | Director | Buy | 5,000 | $2.00 | $10,000.00 | +50.0% |